Advanced Medical Solutions Group plc (AMS), the AIM-listed medical device and wound-care specialist, has published a Rule 2.9 announcement under the City Code on Takeovers and Mergers, confirming the total number of its ordinary shares in issue as at 4 November 2026. The disclosure, required under takeover regulations, confirms that AMS had 221,042,797 ordinary shares of 5 pence each admitted to trading on the AIM Market of the London Stock Exchange. The company confirmed it holds no shares in treasury, meaning the full 221,042,797 shares carry voting rights. Investors will note that a Rule 2.9 disclosure is a regulatory requirement triggered during a formal offer period under the City Code.

Key Points

  • Advanced Medical Solutions Group plc (AMS) — AIM-listed medical device and wound-care company
  • AMS has confirmed 221,042,797 ordinary shares of 5 pence each in issue as at 4 November 2026, with no treasury shares held
  • ISIN for AMS ordinary shares is GB0004536594; LEI number is 213800HJP6OWOSZI1L74
  • Investors should monitor further regulatory disclosures from AMS and any associated parties under Rules 8.1, 8.2, 8.3 and 8.4 of the City Code

AMS Confirms Full Voting Share Count of 221,042,797 on AIM Market

Advanced Medical Solutions Group plc, which develops and manufactures advanced wound-care products and surgical solutions sold across international markets, has stated that all 221,042,797 ordinary shares in issue carry full voting rights. Because the company holds no ordinary shares in treasury, the figure disclosed represents both the total shares in issue and the total voting share capital. This share capital figure is the reference number that must be used by any party required to calculate percentage interests in AMS securities under the disclosure obligations set out in the City Code on Takeovers and Mergers.

Rule 2.9 of the City Code Triggers Formal Share Capital Disclosure for AMS

The announcement was made in compliance with Rule 2.9 of the City Code on Takeovers and Mergers, which requires a company subject to an offer period to publicly confirm its issued share capital and voting rights. The existence of this announcement indicates that AMS is currently within a formal offer period as defined by the Code. The Takeover Panel's disclosure requirements mean that any person holding an interest of 1% or more in AMS ordinary shares must make an Opening Position Disclosure by no later than 3.30 pm London time on the 10th business day following the commencement of the offer period, as the announcement states.

Dealing Disclosure Obligations Apply to Significant AMS Shareholders During Offer Period

Under Rule 8.3 of the City Code, parties holding or acquiring an interest of 1% or more in AMS relevant securities are obliged to make Dealing Disclosures on any business day following a transaction in those securities. The announcement notes that persons acting in concert are treated as a single entity for these purposes. Any relevant dealings must be reported to the Takeover Panel's Market Surveillance Unit. Investors and institutional shareholders with material positions in AMS should ensure they are aware of these obligations for the duration of the offer period, as the announcement explicitly references Rules 8.1, 8.2 and 8.4 as also applying.